Related Experiment Video
Updated: Jan 4, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244
Ya Liu1, Xiaocui He2, Yuli Chen2
1Department of Gynecology, Heze Municipal Hospital, No. 2888 Caozhou Road, Mudan District, Heze, 274000, Shandong, China.
Abstract:
Ovarian cancer (OC) is the most lethal gynecologic malignancy and long non-coding RNAs (lncRNAs) have been acknowledged as important regulators in human OC. This study aimed to investigate the function and underlying mechanisms of LINC00504 in OC. The expression levels of LINC00504 in human OC tissues and cell lines were investigated by qRT-PCR analysis. The OC cell proliferation, and apoptosis were evaluated by MTT assay, colony-formation assay, Caspase-3 activity assay, and nucleosome ELISA assay, respectively. The metabolic shift in OC cells was examined by aerobic glycolysis analysis. Dual-luciferase activity reporter assay and mRNA-miRNA pull-down assay were conducted to validate the interaction between LINC00504 and miR-1244. LINC00504 was upregulated in OC cell lines and specimens. Knockdown of LINC00504 inhibited cell proliferation, enhanced apoptosis, decreased glycolysis-related gene (PKM2, HK2, and PDK1) expression, and altered aerobic glycolysis in OC cells and vice versa. LINC00504 downregulated miR-1244 expression levels by acting as an endogenous sponge of miR-1244. Inhibition of miR-1244 diminished the effects of LINC00504 on OC cells. Our study shows that LINC00504 promotes OC cell progression and stimulates aerobic glycolysis by interacting with miR-1244, which indicates that LINC00504 might act as a promising therapeutic target for OC treatment.
Insights
Long non-coding RNA LINC00504 promotes ovarian cancer (OC) progression and aerobic glycolysis by downregulating miR-1244. This suggests LINC00504 is a potential therapeutic target for ovarian cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality.
- Long non-coding RNAs (lncRNAs) play crucial roles in OC development and progression.
Purpose of the Study:
- To investigate the function of LINC00504 in ovarian cancer.
- To elucidate the underlying molecular mechanisms of LINC00504 in OC progression.
- To explore LINC00504 as a potential therapeutic target for OC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess LINC00504 expression.
- Cell proliferation, apoptosis, and aerobic glycolysis assays (MTT, colony formation, Caspase-3, ELISA, aerobic glycolysis analysis).
- Dual-luciferase reporter and mRNA-miRNA pull-down assays to confirm LINC00504-miR-1244 interaction.
Main Results:
- LINC00504 expression was significantly upregulated in OC tissues and cell lines.
- Knockdown of LINC00504 inhibited OC cell proliferation, induced apoptosis, and decreased aerobic glycolysis.
- LINC00504 acts as an endogenous sponge for miR-1244, downregulating its expression and promoting OC progression.
Conclusions:
- LINC00504 promotes ovarian cancer cell progression and aerobic glycolysis by sponging miR-1244.
- LINC00504 represents a potential therapeutic target for ovarian cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...